The short version of REV-ERB fits in a sentence. The long version — which is the one that helps — is below.
This page was last updated on 2025-10-07 and is reviewed periodically as new material appears.
Detection in biological samples can be complicated by rapid metabolism and low circulating concentrations. Some studies report phase I and phase II metabolites, and analytical methods may need to target those species in addition to the parent compound. Immunoassays are not broadly available, so mass spectrometry remains the main confirmatory approach. For anti-doping testing, laboratories look for SR9009 and its metabolites using validated LC-MS methods. Open questions include how long metabolites remain detectable and how different routes of administration alter detection windows.
In laboratory settings, SR9009 is typically characterized by liquid chromatography–mass spectrometry (LC-MS) or high-performance liquid chromatography with ultraviolet detection (HPLC-UV). These methods can confirm identity and estimate purity, but they require reference standards for accurate quantification. Because SR9009 is not a licensed pharmaceutical, no harmonized pharmacopeial monograph exists. Laboratories often validate in-house methods for matrices such as plasma, urine, or cell culture media. Sample preparation may involve protein precipitation or liquid-liquid extraction before analysis.
Physicochemical behavior influences handling. SR9009 is described as a solid with limited aqueous solubility, so organic solvents such as dimethyl sulfoxide or ethanol are common in research stock solutions. Aqueous dilution can produce precipitates if the organic content is too low. Light, heat, and repeated freeze-thaw cycles may affect stability. Storage recommendations usually specify a desiccated freezer environment protected from light, but exact stability data depend on the formulation and matrix.
Preclinical reports describe effects on exercise endurance, mitochondrial content, and lipid profiles in rodents, but these findings come from specific experimental conditions. Many studies use high doses or delivery methods that may not translate directly to human use. SR9009 has been reported to have low oral bioavailability and a short half-life, which complicates interpretation of oral dosing studies. It is not established as safe or effective for any indication. Literature discussions often separate its pharmacological mechanism from unverified claims made in fitness and supplement markets.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. It is not an approved medicine and has no established human therapeutic use. The compound appears in scientific literature as a tool for probing circadian and metabolic regulation. Online sellers often label it as a research chemical, sometimes using the nickname Stenabolic. Its chemical identity is distinct from selective androgen receptor modulators, stimulants, and peroxisome proliferator-activated receptor delta agonists. Researchers use it mainly in cell and animal experiments.
At the molecular level, SR9009 binds REV-ERBα and REV-ERBβ and alters their repressive activity on target genes. These nuclear receptors help regulate the circadian clock, lipid synthesis, glucose metabolism, and inflammatory pathways. By changing transcription, the compound can shift the timing or magnitude of downstream metabolic processes in model systems. It does not act through androgen receptors or adenosine receptors, which distinguishes it from several substances sold for athletic performance. Whether the same transcriptional changes occur in humans at tolerable exposures remains an open question because controlled human studies are lacking.
| Property | Value | Notes |
|---|---|---|
| Appearance | Off-white to pale yellow solid | Visual description varies with purity and source |
| Solubility | Soluble in DMSO and ethanol; poorly soluble in water | Organic stock solutions are common in research |
| Typical storage | -20 °C, desiccated, protected from light | Avoid repeated freeze-thaw cycles |
| Typical analytical method | LC-MS or HPLC-UV | Reference standards are needed for quantification |
| Molar mass | Approximately 437.9 g/mol | Calculated from the reported free-base formula |
SR9009 is frequently discussed alongside other REV-ERB ligands, including synthetic agonists and natural heme-related molecules. Its selectivity for REV-ERB over related nuclear receptors has been measured in binding and reporter assays, though off-target activity at higher concentrations is possible. The compound is prohibited in sport by the World Anti-Doping Agency, and it is not approved for any medical use in major jurisdictions. Products sold online may be labeled as research chemicals, and their identity and purity are not guaranteed by regulatory review.
SR9009 is a synthetic small molecule that acts on the nuclear receptors REV-ERBα and REV-ERBβ. These receptors are part of the circadian clock machinery and normally repress transcription of certain target genes. In laboratory research, SR9009 is used as a chemical tool to study how REV-ERB activity influences metabolism, inflammation, and daily biological rhythms. The compound is not an approved medicine, and its effects in humans remain largely uncharacterized. It is often described as an investigational agent rather than a therapeutic product.
REV-ERB proteins typically suppress gene expression by recruiting corepressor complexes to DNA response elements. SR9009 binds these receptors and strengthens that repressive action in cell-based assays. Studies in rodents have reported changes in lipid handling, mitochondrial function, and exercise capacity after treatment. Such findings are often cited as evidence for metabolic effects, but species differences and limited pharmacokinetic data make direct translation to humans uncertain. Researchers continue to examine which effects are robust and which depend on specific experimental conditions.
=== August 2008 === On 8 August 2008, Vladimir Socor, the political analyst of Jamestown Foundation, wrote that the Ossetian attacks forced the Georgian Government to respond since sticking to no-response policy "would have resulted in irreparable human, territorial, and political losses" for Georgia and Georgian response was "legally within the country's rights under international law and militarily commensurate with the attacks." Socor also criticized NATO for not giving MAP to Georgia since it provoked Russia to become aggressive towards Georgia. Robert Parsons wrote: "One fact is clear: the Kremlin's troops would not be in South Ossetia today if Georgia were a loyal ally." He argued that Russia was provoked by Kosovo's declaration of independence and Georgia's desire to become a NATO member. On 9 August 2008, Ralph Peters suggested that Russia counted that the world would be distracted by 2008 Summer Olympics and encouraged the Ossetian provocation. Peters wrote on 12 August that he was "seeing the emergence of a rogue military power with a nuclear arsenal" and Russia made it clear that it would not approve of freedom and self-rule in its neighbours. Peters noted that anyone "above the grade of private" knew that such a large-scale Russian "response" was not spontaneous since it was impossible "even to get one armored brigade over the Caucasus Mountains" without lengthy planning." Peters compared the Russian attack on Georgia to German invasion of Czechoslovakia.
== New National Hospital Project == The New National Hospital project (Icelandic: Nýr Landspítali, NLSH) is a large-scale public infrastructure project aimed at replacing the existing facilities of Landspítali. The hospital currently operates across multiple buildings in several locations in the greater Reykjavík area, many of which are said to longer meet modern healthcare requirements.
The four main classes of molecules in biochemistry (often called biomolecules) are carbohydrates, lipids, proteins, and nucleic acids. Many biological molecules are polymers: chains of smaller repeating units called monomers. When monomers are linked together to synthesize a biological polymer, they undergo a process called dehydration synthesis. Macromolecules can assemble in larger complexes with other molecules of the same or different type, often required for biological activity.
Since introducing its Narcotics Safety and Awareness Act, Ontario has committed to focusing on drug addiction, particularly in the monitoring and identification of problem opioid prescriptions, as well as the education of patients, doctors, and pharmacists. This Act, introduced in 2010, commits to the establishment of a unified database to fulfil this intention. Both the public and medical community have received the legislation positively, though concerns about the ramifications of legal changes have been expressed. Because laws are largely provincially regulated, many speculate a national strategy is needed to prevent smuggling across provincial borders from jurisdictions with looser restrictions. In 2015, Purdue Pharma's abuse-resistant OxyNEO and six generic versions of OxyContin had been on the Canada-wide approved list for prescriptions since 2012. In June 2015, then-federal Minister of Health Rona Ambrose announced that within three years, all oxycodone products sold in Canada would need to be tamper-resistant. Some experts warned that the generic product manufacturers may not have the technology to achieve that goal, possibly giving Purdue Pharma a monopoly on this opiate. Several class-action suits across Canada have been launched against the Purdue group of companies and affiliates. Claimants argue the pharmaceutical manufacturers did not meet a standard of care and were negligent in doing so. These lawsuits reference earlier judgments in the United States, which held that Purdue was liable for wrongful marketing practices and misbranding.
Brazil, officially the Federative Republic of Brazil, is the largest country in South America. It is also the world's fifth-largest country by area and the seventh-largest by population, with over 214 million people. Brazil is a federation composed of 26 states and a Federal District, which hosts the capital, Brasília. Its most populous city is São Paulo, followed by Rio de Janeiro. Brazil has the largest Lusophone population in the world and is the only Portuguese-speaking country in the Americas, where it is the official language. Bounded by the Atlantic Ocean on the east, Brazil has a coastline of 7,491 kilometers (4,655 mi), among the longest in the world. Covering roughly half of South America's land area, it borders all other countries and territories on the continent except Ecuador and Chile. Brazil encompasses a wide range of tropical and subtropical landscapes, as well as wetlands, savannas, plateaus, and low mountains. It contains most of the Amazon basin, including the world's largest river system and most extensive virgin tropical forest. Brazil has diverse wildlife, a variety of ecological systems, and extensive natural resources spanning numerous protected habitats. It ranks first among 17 megadiverse countries, with its natural heritage being the subject of significant global interest, as environmental degradation (through processes such as deforestation) directly affect global issues such as climate change and biodiversity loss. Brazil was inhabited by various indigenous peoples prior to the landing of Portuguese explorer Pedro Álvares Cabral in 1500.
Sources: en.wikipedia.org
Tracy Jamal Morgan (born November 10, 1968) is an American stand-up comedian and actor. He was a cast member on the NBC sketch comedy television series Saturday Night Live from 1996 to 2003 and played Tracy Jordan on the NBC sitcom 30 Rock from 2006 to 2013, both of which earned him a Primetime Emmy Award nomination. He also starred as Tray Barker on the TBS comedy The Last O.G.
=== Migraine prevention === In its 2012 guidelines, the American Academy of Neurology stated that high-dose riboflavin (400 mg) is "probably effective and should be considered for migraine prevention," a recommendation also provided by the UK National Migraine Centre. A 2017 review reported that daily riboflavin taken at 400 mg per day for at least three months may reduce the frequency of migraine headaches in adults. Research on high-dose riboflavin for migraine prevention or treatment in children and adolescents is inconclusive, and so supplements are not recommended.
By contrast, the Biden administration's 2022 Review, while prioritizing Ground-based Midcourse Defense, emphasized that it is "neither intended nor capable of defeating" peer-level threats from Russia or China, noting "the interrelationship between strategic offensive arms and strategic defensive systems." While terrestrial defenses developed, the vision of a full space-based shield remained a consistent goal for its proponents. The modern groundwork for the Golden Dome was laid in 2017 by the SDI's former Deputy of Technology, and prominent Team B leader, Michael D. Griffin, who formed the Space Development Agency during the first Trump administration. Griffin long advocated for reusable launch vehicles to make the mass launching of weapons into space economically feasible. While the original Strategic Defense Initiative's attempts at this were short-lived, with the DC-X failing after a series of test flights, Griffin later encouraged and promoted funding of commercial reusable launch vehicles, which have since proven successful. The Heritage Foundation's Project 2025 effort advocated for a Golden Dome-like effort, writing that SpaceX's development of Starlink proves the feasibility of a space-based "overlayer" of thousands of networked satellites and interceptors, broadly similar to the Brilliant Pebbles concept of the 1980s. During his 2024 presidential campaign, Trump repeatedly mentioned the missile shield concept, often to mixed reception.
== External links == The Organic Synthesis Archive Total Synthesis Highlights Total Synthesis News Total syntheses schemes with reaction and reagent indices Group Meeting Problems in Organic Chemistry Archived 2012-04-26 at the Wayback Machine
=== Stomach and kidneys === Cortisol stimulates gastric-acid secretion. Cortisol's only direct effect on the hydrogen-ion excretion of the kidneys is to stimulate the excretion of ammonium ions by deactivating the renal glutaminase enzyme.
Sources: en.wikipedia.org
It is usually detected by LC-MS or HPLC-UV against a reference standard. In biological matrices, metabolite targeting can improve detection. No universal immunoassay is widely available.
The compound is generally handled as light-sensitive and stored cold and dry. Stability in solution depends on solvent, concentration, and storage time. Specific degradation rates are not fully standardized.
Limited water solubility affects formulation for cell and animal studies. Organic co-solvents are often used to dissolve it. Precipitation can confound assay results if not controlled.
SR9009 is a synthetic REV-ERB agonist used in laboratory research. It is not an approved drug, and its effects in humans are not well characterized. It is often sold as a research chemical under the name Stenabolic.